Cargando…

Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

BACKGROUND: In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solut...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannek, Jürgen, Everaert, Karel, Möhr, Sandra, Vance, Will, Van der Aa, Frank, Kesselring, Jürg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346619/
https://www.ncbi.nlm.nih.gov/pubmed/32641131
http://dx.doi.org/10.1186/s12894-020-00650-1
_version_ 1783556433344724992
author Pannek, Jürgen
Everaert, Karel
Möhr, Sandra
Vance, Will
Van der Aa, Frank
Kesselring, Jürg
author_facet Pannek, Jürgen
Everaert, Karel
Möhr, Sandra
Vance, Will
Van der Aa, Frank
Kesselring, Jürg
author_sort Pannek, Jürgen
collection PubMed
description BACKGROUND: In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solution remains yet to be determined. In vitro studies demonstrate that polihexanide is a promising option for catheter irrigation, but no data about safety and tolerability exist. METHODS: In a prospective observational study in patients with indwelling bladder catheter for > 2 weeks, a 0.02% polihexanide solution was used to rinse the catheter on five consecutive days. Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period. RESULTS: There was no serious adverse event in the study. A total of 28 adverse events (AEs) in 15 (46.88%) participants were experienced. Absolute changes in pain scores were not clinically relevant. No incidences of either flushing or sweating were found during instillation. Bladder spasms during instillation were reported in two cases during a single instillation. Mean pulse rates did not change by more than 3 beats per minute. Mean changes in body temperature did not exceed 0.12 °C. Clinically relevant changes in blood pressure were recorded for 3 patients. CONCLUSIONS: This is the first study to demonstrate that a 0.02% polihexanide solution can safely be used for catheter irrigation. TRIAL REGISTRATION: ClinicalTrials.gov (NCT02157415), June 6th, 2014.
format Online
Article
Text
id pubmed-7346619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73466192020-07-14 Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study Pannek, Jürgen Everaert, Karel Möhr, Sandra Vance, Will Van der Aa, Frank Kesselring, Jürg BMC Urol Research Article BACKGROUND: In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solution remains yet to be determined. In vitro studies demonstrate that polihexanide is a promising option for catheter irrigation, but no data about safety and tolerability exist. METHODS: In a prospective observational study in patients with indwelling bladder catheter for > 2 weeks, a 0.02% polihexanide solution was used to rinse the catheter on five consecutive days. Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period. RESULTS: There was no serious adverse event in the study. A total of 28 adverse events (AEs) in 15 (46.88%) participants were experienced. Absolute changes in pain scores were not clinically relevant. No incidences of either flushing or sweating were found during instillation. Bladder spasms during instillation were reported in two cases during a single instillation. Mean pulse rates did not change by more than 3 beats per minute. Mean changes in body temperature did not exceed 0.12 °C. Clinically relevant changes in blood pressure were recorded for 3 patients. CONCLUSIONS: This is the first study to demonstrate that a 0.02% polihexanide solution can safely be used for catheter irrigation. TRIAL REGISTRATION: ClinicalTrials.gov (NCT02157415), June 6th, 2014. BioMed Central 2020-07-08 /pmc/articles/PMC7346619/ /pubmed/32641131 http://dx.doi.org/10.1186/s12894-020-00650-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Pannek, Jürgen
Everaert, Karel
Möhr, Sandra
Vance, Will
Van der Aa, Frank
Kesselring, Jürg
Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title_full Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title_fullStr Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title_full_unstemmed Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title_short Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
title_sort tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346619/
https://www.ncbi.nlm.nih.gov/pubmed/32641131
http://dx.doi.org/10.1186/s12894-020-00650-1
work_keys_str_mv AT pannekjurgen tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy
AT everaertkarel tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy
AT mohrsandra tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy
AT vancewill tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy
AT vanderaafrank tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy
AT kesselringjurg tolerabilityandsafetyofurotainerpolihexanide002incatheterizedpatientsaprospectivecohortstudy